Home > Share Market > Stocks > Glaxosmithkline pharmaceuticals > Financial Statements > GLAXO Balance Sheet

Glaxosmithkline Pharmaceuticals Ltd Financial Statements

Glaxosmithkline Pharmaceuticals Ltd Balance Sheet

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2019
Equity capital 169 169 169 169
Preference capital -- -- -- --
Reserves 2,494 1,309 1,651 1,970
Net worth 2,663 1,478 1,821 2,140
Minority interest
Debt -- 0.02 0.18 0.58
Deferred tax liabilities (net) 18.90 15.60 17.20 24.10
Total liabilities 2,682 1,494 1,838 2,165
Fixed assets 361 400 878 1,434
Intangible assets
Investments 366 -- -- 0.06
Deferred tax asset (net) 132 119 128 86.30
Net working capital (661) (183) (251) (527)
Inventories 535 547 483 486
Inventory Days 59.50 68.20 54.70 --
Sundry debtors 205 216 99.80 120
Debtor days 22.90 26.90 11.30 --
Other current assets 569 691 479 636
Sundry creditors (572) (468) (381) (483)
Creditor days 63.70 58.40 43.10 --
Other current liabilities (1,398) (1,168) (931) (1,288)
Cash 2,485 1,158 1,083 1,171
Total assets 2,682 1,494 1,838 2,165

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000